Skip to content

Clinical trials

Phase 3 Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Embolism Phase: Phase 3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20064
20082
20092
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCA Biopharma, Inc.2
Daiichi Sankyo Co., Ltd.2
Sanofi2
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Universitaire de Nīmes1
Daiichi Sankyo1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
National Heart, Lung, and Blood Institute (NHLBI)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Embolism12
Thrombosis7
Stroke4
Thromboembolism4
Venous Thrombosis4
Atrial Fibrillation3
Arterial Occlusive Diseases2
Intermittent Claudication2
Venous Thromboembolism2
Acute Coronary Syndrome1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.